Benzylamine → N*4*-Benzyl-3-bromo-1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
Reaction equation
[Br:1][C:2]1[C:10]2[C:5](=[N:6][C:7]([NH2:12])=[N:8][C:9]=2Cl)[N:4]([CH3:13])[N:3]=1.[CH2:14]([NH2:21])[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1>CN(C=O)C>[CH2:14]([NH:21][C:9]1[N:8]=[C:7]([NH2:12])[N:6]=[C:5]2[N:4]([CH3:13])[N:3]=[C:2]([Br:1])[C:10]=12)[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1Participants
4
Conditions
- Temperature
- 40 °C
Procedure
3-Bromo-4-chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-ylamine (Intermediate 14) (160 mg, 0.61 mmol), benzylamine (0.2 ml, 1.83 mmol) and DMF (5 ml) are mixed together and heated at 40° C. overnight. After cooling to room temperature the solvent is removed in vacuo and the residue is dissolved in methanol (30 ml) and passed through an Isolute™ CBA column (silica based carboxylic acid sorbent). Silica gel is added to the filtrate, the solvent is removed in vacuo and the resulting residue is flash chromatographed eluting with EtOAc:iso-hexanes (4:6) and then increasing to EtOAc:iso-hexanes (1:1). The appropriate fractions are collected and concentrated in vacuo to afford the title compound.
Workup
- temperatureAfter cooling to room temperature the solvent
- customis removed in vacuo
- dissolutionthe residue is dissolved in methanol (30 ml)
- additionSilica gel is added to the filtrate
- customthe solvent is removed in vacuo
- customchromatographed
- washeluting with EtOAc:iso-hexanes (4:6)
- temperatureincreasing to EtOAc:iso-hexanes (1:1)
- customThe appropriate fractions are collected
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-5577f1745fc241ddb4946e2bc09aef1b
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08901134B2
Reaction notes
Loading…